|
TCEAL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62547753035369E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
8.1144000000033E-05 |
| Normal-vs-Stage3 |
2.50739999996252E-06 |
| Normal-vs-Stage4 |
2.11189999999029E-05 |
| Stage1-vs-Stage2 |
4.242000E-01 |
| Stage1-vs-Stage3 |
5.690200E-02 |
| Stage1-vs-Stage4 |
9.141800E-01 |
| Stage2-vs-Stage3 |
7.631800E-01 |
| Stage2-vs-Stage4 |
5.389800E-01 |
| Stage3-vs-Stage4 |
2.662000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62680979798324E-12 |
| Normal-vs-AfricanAmerican |
2.05069999870133E-08 |
| Normal-vs-Asian |
1.106240E-02 |
| Caucasian-vs-AfricanAmerican |
1.879200E-01 |
| Caucasian-vs-Asian |
3.683600E-01 |
| AfricanAmerican-vs-Asian |
7.034600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.14019999997161E-06 |
| Male-vs-Female |
7.975900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.19830001477084E-09 |
| Normal-vs-Extreme_Weight |
1.62558855265615E-12 |
| Normal-vs-Obese |
1.24229999620695E-08 |
| Normal-vs-Extreme_Obese |
1.59868999999313E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.798600E-01 |
| Normal_Weight-vs-Obese |
5.247800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.114600E-01 |
| Extreme_Weight-vs-Obese |
6.824300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.186800E-01 |
| Obese-vs-Extreme_Obese |
3.432800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.81710000000313E-05 |
| Normal-vs-Age(41-60Yrs) |
1.16562315355395E-12 |
| Normal-vs-Age(61-80Yrs) |
4.53304060954451E-13 |
| Normal-vs-Age(81-100Yrs) |
1.91910000002515E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.658800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.860400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.733200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.823040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.186000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.450800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
4.16400247615911E-11 |
| Normal-VS-KIRP CIMP |
6.30440000000121E-05 |
| Normal-VS-Unclassified PRCC |
2.03739999982133E-07 |
| Type1 PRCC-VS-Type2 PRCC |
9.971800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.248400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.891900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.598400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.892400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.373000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.81069603755191E-11 |
| Normal-vs-N1 |
6.19989999999238E-05 |
| Normal-vs-N2 |
5.623000E-03 |
| N0-vs-N1 |
1.514380E-01 |
| N0-vs-N2 |
9.485000E-01 |
| N1-vs-N2 |
5.982400E-01 |
|
|
